Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
   D01 ANTIFUNGALS FOR DERMATOLOGICAL USE
   D02 EMOLLIENTS AND PROTECTIVES
   D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS
   D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
   D05 ANTIPSORIATICS
   D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
   D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
   D08 ANTISEPTICS AND DISINFECTANTS
   D09 MEDICATED DRESSINGS
   D10 ANTI-ACNE PREPARATIONS
     D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE
       D10AA Corticosteroids, combinations for treatment of acne
       D10AB Preparations containing sulfur
       D10AD Retinoids for topical use in acne
         D10AD01 Tretinoin [DG:DG00433]
           D00094  Tretinoin (JAN/USP/INN) <JP/US>
           D01516  Tretinoin tocoferil (JAN) <JP>
         D10AD02 Retinol [DG:DG00123]
         D10AD03 Adapalene
         D10AD04 Isotretinoin [DG:DG00434]
         D10AD05 Motretinide
         D10AD06 Trifarotene
         D10AD51 Tretinoin, combinations
         D10AD53 Adapalene, combinations
         D10AD54 Isotretinoin, combinations
       D10AE Peroxides
       D10AF Antiinfectives for treatment of acne
       D10AX Other anti-acne preparations for topical use
     D10B ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE
   D11 OTHER DERMATOLOGICAL PREPARATIONS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
   L01 ANTINEOPLASTIC AGENTS
     L01A ALKYLATING AGENTS
     L01B ANTIMETABOLITES
     L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
     L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
     L01E PROTEIN KINASE INHIBITORS
     L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
     L01X OTHER ANTINEOPLASTIC AGENTS
       L01XA Platinum compounds [DG:DG01679]
       L01XB Methylhydrazines
       L01XD Sensitizers used in photodynamic/radiation therapy
       L01XF Retinoids for cancer treatment
         L01XF01 Tretinoin [DG:DG00433]
           D00094  Tretinoin (JAN/USP/INN) <JP/US>
           D01516  Tretinoin tocoferil (JAN) <JP>
         L01XF02 Alitretinoin
         L01XF03 Bexarotene
       L01XG Proteasome inhibitors [DG:DG03134]
       L01XH Histone deacetylase (HDAC) inhibitors [DG:DG03133]
       L01XJ Hedgehog pathway inhibitors [DG:DG01566]
       L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors [DG:DG02942]
       L01XL Antineoplastic cell and gene therapy
       L01XX Other antineoplastic agents
       L01XY Combinations of antineoplastic agents
   L02 ENDOCRINE THERAPY
   L03 IMMUNOSTIMULANTS
   L04 IMMUNOSUPPRESSANTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: April 22, 2024
According to WHO's ATC 2024

» Japanese version